Compare TOI & HPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOI | HPF |
|---|---|---|
| Founded | 2007 | N/A |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.6M | 349.2M |
| IPO Year | N/A | 2002 |
| Metric | TOI | HPF |
|---|---|---|
| Price | $2.59 | $16.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 36.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.51 | N/A |
| Revenue Next Year | $25.30 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $14.56 |
| 52 Week High | $4.88 | $17.21 |
| Indicator | TOI | HPF |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 51.33 |
| Support Level | $2.32 | $16.10 |
| Resistance Level | $2.73 | $16.25 |
| Average True Range (ATR) | 0.22 | 0.09 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 47.37 | 53.40 |
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
John Hancock Preferred Income Fund II is the United States based closed-end, diversified management investment company. Its primary objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. The fund's principal investment strategies include to invests a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, capital preferred securities and short-term investments.